RxDoctor Payments Data

Stephen Eliason, MD

Anatomic Pathology & Clinical Pathology · Lawrenceburg, INNPI 1700868767

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $443 and has fallen 52.4% since, to $211 in 2025.

$1,078in general payments, 2019–2025

Across 55 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • QOL Medical, LLC$183
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$150
  • Regeneron Healthcare Solutions, Inc.$122
  • Takeda Pharmaceuticals U.S.A., Inc.$104
  • Lilly USA, LLC$92
  • Johnson & Johnson$79
  • plus $350 from 10 others

What the payments were for

  • Food & beverage$1,06098%
  • Education$182%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,078 in reported general payments places this provider in the 85th percentile of 137 anatomic pathology & clinical pathology providers in Indiana.

See all anatomic pathology & clinical pathology providers in Indiana

Medicare billing

Part B allowed, 2024
$355,965
Medicare patients
3,320
Services billed
7,982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Lawrenceburg

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →